• 2',7'-Dichlorofluorescein diacetate: ROS Guide

  2026-08-30

  Build a practical intracellular ROS measurement workflow with 2',7'-Dichlorofluorescein diacetate across microscopy, flow cytometry, and plate assays. The guide also explains how to use this broad redox readout to interrogate ROS-responsive nanocarriers without overstating what the fluorescence signal proves.

• EdU Flow Cytometry Assay Kits (Cy5) Guide

  2026-08-29

  EdU Flow Cytometry Assay Kits (Cy5) provide an endpoint method for quantifying DNA synthesis during S phase by labeling incorporated EdU with a Cy5 azide through copper-catalyzed click chemistry. The assay is suited to fixed-cell flow cytometry, cell-cycle analysis, and treatment-response studies, but not to live-cell imaging or workflows that cannot tolerate copper-catalyzed chemistry.

• H 89 2HCl: From PKA Mechanism to Translation

  2026-08-28

  A mechanistic and strategic guide to using H 89 2HCl for interrogating cAMP/PKA signaling, neuronal calcium dynamics, protein phosphorylation, and translational assay design.

• From DEVD Signal to Translational Apoptosis Insight

  2026-08-28

  A mechanistic and strategic guide to using DEVD-dependent caspase-3 activity as a functional bridge between cell-death biology, assay validation, and translational decision-making.

• Ibrexafungerp: From MICs to In Vivo Evidence

  2026-08-27

  Ibrexafungerp, also known as MK 3118, links a distinct glucan-synthase mechanism with oral exposure and activity against resistant Candida. This article explains how susceptibility assays and delayed-treatment animal models improve translational interpretation.

• PEP, cGAS–STING, and Healthy Aging

  2026-08-27

  The reference study identifies phosphoenolpyruvate (PEP) as an age-responsive glycolytic metabolite that restrains cGAS–STING-driven inflammation. Its longitudinal, mechanistic, and disease-model evidence connects metabolic state with inflammaging while also showing why PEP findings should not be directly equated with evidence for hexose diphosphate.

• SNS-032: Reading CDK9 and RNA Pol II Signals

  2026-08-26

  SNS-032 (BMS-387032) is a selective CDK2, CDK7, and CDK9 inhibitor whose RNA Pol II phosphorylation profile can connect kinase engagement with transcriptional and cancer phenotypes. This article develops an assay-centered framework and carefully distinguishes SNS-032 evidence from related CDK9 findings in SARS-CoV-2 research.

• EDTA-Free Protease Inhibitor for OXPHOS Assays

  2026-08-26

  Discover how a Protease Inhibitor Cocktail supports reliable OXPHOS cancer assays by preserving protein integrity during extraction. This guide connects EDTA-free protease control with LRPPRC–dasatinib mechanism validation and practical assay design.

• YTHDF1 Phase Separation in SSC Fate Transition

  2026-08-25

  Fang et al. show that liquid-liquid phase separation by the m6A reader YTHDF1 promotes direct conversion of spermatogonial stem cells into neural stem cell-like cells. The work connects YTHDF1 condensates to selective suppression of IκBα/β mRNA translation and activation of the IκB–NF-κB–CCND1 axis, providing a mechanistic framework for studying RNA-mediated cell-fate transitions.

• Metabolic Intervention for Ferroptosis and Cuproptosis

  2026-08-25

  The 2024 Chemical Engineering Journal study develops a copper-based liposome nanosystem that combines glycolysis and NAD+ metabolic intervention with copper delivery to sensitize tumors to ferroptosis and cuproptosis. By weakening antioxidant capacity, ATP-dependent copper export, and tumor metabolic support, the strategy also promotes immunogenic cell death and antitumor immune activity.

• α-Linolenic Acid: Applied Research Workflows

  2026-08-24

  Build reproducible ALA experiments around lipid flux, cardiovascular phenotypes, inflammation, and carefully bounded immune assays. This guide combines practical dosing, storage, controls, and troubleshooting with a clear distinction between evidence for α-Linolenic Acid and findings reported for arachidonic acid.

• Camostat Mesilate: From Protease Tool to Assay Logic

  2026-08-24

  Camostat Mesilate is a trypsin-like protease inhibitor whose value spans ENaC biology, plasmin–TGF-β signaling, and fibrosis research. This article develops an assay-selection framework that distinguishes protease modulation from structure-guided protein–protein interaction inhibition.

• How Kinase Inhibitors Tune p38α Dephosphorylation

  2026-08-23

  The reference preprint identifies a dual-action mode in which selected p38α MAP kinase inhibitors both suppress kinase activity and accelerate WIP1-mediated dephosphorylation of the activation loop. Biochemical assays and X-ray structures link this effect to an inhibitor-stabilized activation-loop conformation that exposes the phospho-threonine, suggesting a route toward greater kinase-inhibitor specificity beyond active-site binding alone.

• PCR Fidelity in Neurodegeneration Research

  2026-08-22

  Translational neuroscience increasingly depends on molecular measurements that remain trustworthy across complex templates, environmental exposures, and high-throughput workflows. This article examines how mechanistic findings in C. elegans neurodegeneration create a practical need for accurate amplification and explains where HyperFusion™ high-fidelity DNA polymerase can strengthen cloning, genotyping, and sequencing strategies without overstating what PCR alone can prove.

• IWP-2: Designing Better Wnt Perturbation Assays

  2026-08-21

  IWP-2 is a potent Wnt production inhibitor for dissecting PORCN-dependent signaling and cancer phenotypes. This guide develops an assay-design framework that connects pathway pharmacology with single-nucleus profiling principles while defining appropriate evidence boundaries.

8236 records 1/550 page Next 12345 下5页 Last page